SlideShare una empresa de Scribd logo

Development And Review Process Of NDA, ANDA/AADA and OTC

•Descargar como PPT, PDF•
•
Prof. Dr. Basavaraj Nanjwade
Prof. Dr. Basavaraj Nanjwade

This document summarizes different types of new drug applications and reviews processes in the United States, including NDAs, ANDAs, and OTC monographs. It discusses the requirements for NDAs including chemistry, manufacturing, clinical trials, and safety data. ANDAs allow for generic drug approval by referencing an already approved drug. OTC monographs provide standards for active ingredients, doses, and labeling of non-prescription drugs. The review processes for these application types and OTC monographs are also briefly outlined.

EducaciónSalud y medicinaEmpresariales
1 de 16
Development and Review Process of NDA, ANDA/AADA and OTC Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Associate Professor Department of Pharmaceutics KLE University BELGAUM – 590 010
New Drug Development Process
Fundamentals of NDA Submissions ,[object Object],[object Object],[object Object],[object Object],[object Object]
Fundamentals of NDA Submissions ,[object Object],[object Object],[object Object],[object Object]
Fundamentals of NDA Submissions ,[object Object],[object Object],[object Object],[object Object],[object Object]
New Drug Application (NDA) Classifications ,[object Object],[object Object],[object Object],[object Object]
New Drug Application (NDA) Classifications ,[object Object],[object Object],[object Object]
NDA Review Process
ANDA/AADA (Abbreviated New Drug Application) ,[object Object]
ANDA/AADA (Abbreviated New Drug Application) ,[object Object],[object Object],[object Object]
ANDA/AADA (Abbreviated New Drug Application) ,[object Object],[object Object]
ANDA/AADA Review Process
OTC (Over-the-Counter Drug Products) ,[object Object],[object Object],[object Object]
OTC (Over-the-Counter Drug Products) ,[object Object],[object Object],[object Object]
OTC Drug Monograph Review Process
THANK YOU E-mail: [email_address] Cell No: 09448716277

Recomendados

ACTD Guidelines Overview
ACTD Guidelines OverviewACTD Guidelines Overview
ACTD Guidelines OverviewMuhammad Ali Jehangir
 
eCTD
eCTDeCTD
eCTDCyclone Pharmaceutical Pvt Ltd
 
Orange book
Orange bookOrange book
Orange bookRucha Pathak
 
Abbreviated New Drug Application [ANDA]
Abbreviated New Drug Application [ANDA]Abbreviated New Drug Application [ANDA]
Abbreviated New Drug Application [ANDA]Sagar Savale
 
Distribution records
Distribution recordsDistribution records
Distribution recordsJyotiMhoprekar
 
How to apply for COPPs (Certificate of Pharmaceutical Products)?
How to apply for COPPs (Certificate of Pharmaceutical Products)?How to apply for COPPs (Certificate of Pharmaceutical Products)?
How to apply for COPPs (Certificate of Pharmaceutical Products)?ambitbiomedix12
 
CTD and eCTD
CTD and eCTDCTD and eCTD
CTD and eCTDGirish Swami
 
Pharmaceutical development report (pdr)
Pharmaceutical development report (pdr)Pharmaceutical development report (pdr)
Pharmaceutical development report (pdr)Atul Bhombe
 

Recomendados

ACTD Guidelines Overview
ACTD Guidelines OverviewACTD Guidelines Overview
ACTD Guidelines OverviewMuhammad Ali Jehangir
 
eCTD
eCTDeCTD
eCTDCyclone Pharmaceutical Pvt Ltd
 
Orange book
Orange bookOrange book
Orange bookRucha Pathak
 
Abbreviated New Drug Application [ANDA]
Abbreviated New Drug Application [ANDA]Abbreviated New Drug Application [ANDA]
Abbreviated New Drug Application [ANDA]Sagar Savale
 
Distribution records
Distribution recordsDistribution records
Distribution recordsJyotiMhoprekar
 
How to apply for COPPs (Certificate of Pharmaceutical Products)?
How to apply for COPPs (Certificate of Pharmaceutical Products)?How to apply for COPPs (Certificate of Pharmaceutical Products)?
How to apply for COPPs (Certificate of Pharmaceutical Products)?ambitbiomedix12
 
CTD and eCTD
CTD and eCTDCTD and eCTD
CTD and eCTDGirish Swami
 
Pharmaceutical development report (pdr)
Pharmaceutical development report (pdr)Pharmaceutical development report (pdr)
Pharmaceutical development report (pdr)Atul Bhombe
 
Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical DocumentDr Sukanta sen
 
DMF Drug Master File
DMF Drug Master FileDMF Drug Master File
DMF Drug Master FileRushi Mendhe
 
Hatch Waxman Act
Hatch Waxman ActHatch Waxman Act
Hatch Waxman ActNaveen Kumar
 
3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptx3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptxKrishnapriyaVH1
 
Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Md. Zakaria Faruki
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 
Post approval of drugs
Post approval of drugsPost approval of drugs
Post approval of drugsSunil Boreddy Rx
 
Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Surendra Singh
 
Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)suresh gautam
 
ICH [ Q ] Guidelines
ICH [ Q ] GuidelinesICH [ Q ] Guidelines
ICH [ Q ] GuidelinesAbhishekPatil387
 
Abbreviated new drug application submission
Abbreviated new drug application submissionAbbreviated new drug application submission
Abbreviated new drug application submissionGaurav Sharma
 
New drug application
New drug applicationNew drug application
New drug applicationnishuyadav17
 
Ctd and e ctd
Ctd and e ctdCtd and e ctd
Ctd and e ctdBashant Kumar sah
 
Clinical research protocols
Clinical research protocolsClinical research protocols
Clinical research protocolsMouryaDeep
 
Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Nipun Gupta
 
PMS (post marketing surveillance)
PMS (post marketing surveillance)PMS (post marketing surveillance)
PMS (post marketing surveillance)SANDEEP LOHMOR
 
NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)GOKULAKRISHNAN S
 
Regulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologicsRegulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologicsNimmiRoy
 
Ctd ppt
Ctd pptCtd ppt
Ctd pptMalla Reddy College of Pharmacy
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)Suvarta Maru
 
IPR NDA and ANDA
IPR NDA and ANDAIPR NDA and ANDA
IPR NDA and ANDAmahender Kotte
 
NDA_ANDA_IND.docx
NDA_ANDA_IND.docxNDA_ANDA_IND.docx
NDA_ANDA_IND.docxArchiPatel49
 

Más contenido relacionado

La actualidad más candente

Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical DocumentDr Sukanta sen
 
DMF Drug Master File
DMF Drug Master FileDMF Drug Master File
DMF Drug Master FileRushi Mendhe
 
3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptx3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptxKrishnapriyaVH1
 
Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Md. Zakaria Faruki
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 
Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Surendra Singh
 
Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)suresh gautam
 
Abbreviated new drug application submission
Abbreviated new drug application submissionAbbreviated new drug application submission
Abbreviated new drug application submissionGaurav Sharma
 
New drug application
New drug applicationNew drug application
New drug applicationnishuyadav17
 
Clinical research protocols
Clinical research protocolsClinical research protocols
Clinical research protocolsMouryaDeep
 
Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Nipun Gupta
 
PMS (post marketing surveillance)
PMS (post marketing surveillance)PMS (post marketing surveillance)
PMS (post marketing surveillance)SANDEEP LOHMOR
 
NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)GOKULAKRISHNAN S
 
Regulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologicsRegulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologicsNimmiRoy
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)Suvarta Maru
 

La actualidad más candente (20)

Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical Document
 
DMF Drug Master File
DMF Drug Master FileDMF Drug Master File
DMF Drug Master File
 
Hatch Waxman Act
Hatch Waxman ActHatch Waxman Act
Hatch Waxman Act
 
3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptx3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptx
 
Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 
Post approval of drugs
Post approval of drugsPost approval of drugs
Post approval of drugs
 
Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)
 
Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)
 
ICH [ Q ] Guidelines
ICH [ Q ] GuidelinesICH [ Q ] Guidelines
ICH [ Q ] Guidelines
 
Abbreviated new drug application submission
Abbreviated new drug application submissionAbbreviated new drug application submission
Abbreviated new drug application submission
 
New drug application
New drug applicationNew drug application
New drug application
 
Ctd and e ctd
Ctd and e ctdCtd and e ctd
Ctd and e ctd
 
Clinical research protocols
Clinical research protocolsClinical research protocols
Clinical research protocols
 
Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)
 
PMS (post marketing surveillance)
PMS (post marketing surveillance)PMS (post marketing surveillance)
PMS (post marketing surveillance)
 
NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)
 
Regulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologicsRegulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologics
 
Ctd ppt
Ctd pptCtd ppt
Ctd ppt
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)
 

Similar a Development And Review Process Of NDA, ANDA/AADA and OTC

ANDA FDA APPLICATION
ANDA FDA APPLICATIONANDA FDA APPLICATION
ANDA FDA APPLICATIONRoshan Bodhe
 
Non-clinical drug development
Non-clinical drug developmentNon-clinical drug development
Non-clinical drug developmentJayeshRajput7
 
INDA- Investigation New Drug Application
INDA- Investigation New Drug ApplicationINDA- Investigation New Drug Application
INDA- Investigation New Drug ApplicationDr. Jigar Vyas
 
Overview of Biopharmaceuticals -basics for students
Overview of Biopharmaceuticals -basics for studentsOverview of Biopharmaceuticals -basics for students
Overview of Biopharmaceuticals -basics for studentssatheeshpinkworld
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
US FDA Regulatory Submissions
US FDA Regulatory SubmissionsUS FDA Regulatory Submissions
US FDA Regulatory SubmissionsChandra Mohan
 
Abbreviated New Drug Application ANDA ppt
Abbreviated New Drug Application ANDA pptAbbreviated New Drug Application ANDA ppt
Abbreviated New Drug Application ANDA pptAkanksha Puri
 
Anda 120822221703-phpapp01
Anda 120822221703-phpapp01Anda 120822221703-phpapp01
Anda 120822221703-phpapp01Deshmukh Ishrar
 
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...Audumbar Mali
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesChintamBaladattaSai
 

Similar a Development And Review Process Of NDA, ANDA/AADA and OTC (20)

IPR NDA and ANDA
IPR NDA and ANDAIPR NDA and ANDA
IPR NDA and ANDA
 
NDA_ANDA_IND.docx
NDA_ANDA_IND.docxNDA_ANDA_IND.docx
NDA_ANDA_IND.docx
 
ANDA , NDA.pptx
ANDA , NDA.pptxANDA , NDA.pptx
ANDA , NDA.pptx
 
ANDA FDA APPLICATION
ANDA FDA APPLICATIONANDA FDA APPLICATION
ANDA FDA APPLICATION
 
Non-clinical drug development
Non-clinical drug developmentNon-clinical drug development
Non-clinical drug development
 
NDA Vs ANDA
NDA Vs ANDANDA Vs ANDA
NDA Vs ANDA
 
INDA- Investigation New Drug Application
INDA- Investigation New Drug ApplicationINDA- Investigation New Drug Application
INDA- Investigation New Drug Application
 
Overview of Biopharmaceuticals -basics for students
Overview of Biopharmaceuticals -basics for studentsOverview of Biopharmaceuticals -basics for students
Overview of Biopharmaceuticals -basics for students
 
ANDA
ANDAANDA
ANDA
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
INDA/NDA/ANDA
INDA/NDA/ANDAINDA/NDA/ANDA
INDA/NDA/ANDA
 
US FDA Regulatory Submissions
US FDA Regulatory SubmissionsUS FDA Regulatory Submissions
US FDA Regulatory Submissions
 
Nda ipr
Nda iprNda ipr
Nda ipr
 
Abbreviated New Drug Application ANDA ppt
Abbreviated New Drug Application ANDA pptAbbreviated New Drug Application ANDA ppt
Abbreviated New Drug Application ANDA ppt
 
Anda 120822221703-phpapp01
Anda 120822221703-phpapp01Anda 120822221703-phpapp01
Anda 120822221703-phpapp01
 
ANDA
ANDAANDA
ANDA
 
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agencies
 
Nda
NdaNda
Nda
 
Barbara Sabourin regulating drugs in canada v2
Barbara Sabourin regulating drugs in canada v2Barbara Sabourin regulating drugs in canada v2
Barbara Sabourin regulating drugs in canada v2
 

Más de Prof. Dr. Basavaraj Nanjwade

Good laboratory practices for pharmaceuticals and biopharmaceuticals
Good laboratory practices for pharmaceuticals and biopharmaceuticalsGood laboratory practices for pharmaceuticals and biopharmaceuticals
Good laboratory practices for pharmaceuticals and biopharmaceuticalsProf. Dr. Basavaraj Nanjwade
 
Packaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for PharmaceuticalsPackaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for PharmaceuticalsProf. Dr. Basavaraj Nanjwade
 
QbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage FormsQbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage FormsProf. Dr. Basavaraj Nanjwade
 
Development, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological productsDevelopment, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological productsProf. Dr. Basavaraj Nanjwade
 
Clinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsClinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsProf. Dr. Basavaraj Nanjwade
 

Más de Prof. Dr. Basavaraj Nanjwade (20)

COVID-19 and Novel Drug Delivery System.ppt
COVID-19 and Novel Drug Delivery System.pptCOVID-19 and Novel Drug Delivery System.ppt
COVID-19 and Novel Drug Delivery System.ppt
 
Good laboratory practices for pharmaceuticals and biopharmaceuticals
Good laboratory practices for pharmaceuticals and biopharmaceuticalsGood laboratory practices for pharmaceuticals and biopharmaceuticals
Good laboratory practices for pharmaceuticals and biopharmaceuticals
 
Opportunities and future for pharmacist
Opportunities and future for pharmacistOpportunities and future for pharmacist
Opportunities and future for pharmacist
 
Opportunities and future for pharmacist
Opportunities and future for pharmacistOpportunities and future for pharmacist
Opportunities and future for pharmacist
 
Novel drug delivery system
Novel drug delivery systemNovel drug delivery system
Novel drug delivery system
 
Packaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for PharmaceuticalsPackaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for Pharmaceuticals
 
QbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage FormsQbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage Forms
 
Opportunities and Future for Pharma Buddies
Opportunities and Future for Pharma BuddiesOpportunities and Future for Pharma Buddies
Opportunities and Future for Pharma Buddies
 
Development of Clinical Formulation
Development of Clinical FormulationDevelopment of Clinical Formulation
Development of Clinical Formulation
 
QbD for Pharma Products Development
QbD for Pharma Products DevelopmentQbD for Pharma Products Development
QbD for Pharma Products Development
 
Development, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological productsDevelopment, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological products
 
Clinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsClinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural products
 
Clinical drug design
Clinical drug designClinical drug design
Clinical drug design
 
Clinical drug development
Clinical drug developmentClinical drug development
Clinical drug development
 
Clinical drug design
Clinical drug designClinical drug design
Clinical drug design
 
Solid dosage forms (tablets)
Solid dosage forms (tablets)Solid dosage forms (tablets)
Solid dosage forms (tablets)
 
Solid dosage forms (capsules)
Solid dosage forms (capsules)Solid dosage forms (capsules)
Solid dosage forms (capsules)
 
Preparations in pharmacy of hospital
Preparations in pharmacy of hospitalPreparations in pharmacy of hospital
Preparations in pharmacy of hospital
 
Injectable solutions
Injectable solutionsInjectable solutions
Injectable solutions
 
Aerosols
AerosolsAerosols
Aerosols
 

Último

Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
mini mental status format.docx
mini mental status format.docxmini mental status format.docx
mini mental status format.docxPoojaSen20
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 

Último (20)

Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
mini mental status format.docx
mini mental status format.docxmini mental status format.docx
mini mental status format.docx
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 

Development And Review Process Of NDA, ANDA/AADA and OTC